Stock price when the opinion was issued
It has had issues and it has been a tough year facing several challenges. Owns it in the global equity fund. He is waiting for the conference call tomorrow which should talk about how the issues are being dealt with. They have pulled their guidance on EPS and the new CEO could be putting out a new guidance level. Wait for the base line to grow but there is long term upside.
Nothing is too big to fail, but UNH is so integrated into the US healthcare system that they are an essential service. Problem is more people are getting utilization in areas that are higher cost. So, their estimates got blown out. Has long owned this. He recommended it for its multiyear consistent earnings. They just reported and are guiding resumption of growth in 2026. Is at a 35% discount to its 3-year forward earnings. He was buying this morning on their earnings call.
Numbers are fantastic, nothing wrong there. Potential fraud, being investigated. You can't quantify something like that. When he doesn't know, he has to step aside. There's already enough risk in the stock market when you buy the "perfect" company, and it can still go down 10%. He's willing to miss a bit of any upside and wait for a resolution to the story.
Dark clouds are concern about overstated revenues plus current regulatory environment. If you want to invest in something and look like a hero a year from now, you could take a very small percentage. Taking on risk if something else blows up. Can't see a basing pattern yet.
Stock's PE is cheap, but he sees negative earnings growth over next few years. Reports of hedge fund companies getting in is a positive. Very oversold.
On top of medical loss ratio issue, now being investigated by DOJ on billing practices. Suspects this will be like a WFC scenario -- clouds will hang over the name and will take a long time to clear. EPS revised down from $25 to $16, so who knows what they'll actually be by year's end.
Likes HMOs in general as a business that reprices YOY. If you're a very long-term investor and you want to take a stab, it's not going away anytime soon. But expect a bumpy ride for the next 1-6 quarters.
Is up 10% in the past month. Don't chase a red hot stock, but let it come in a bit (lower). Every time this spikes, it goes down. It's best of breed.